PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsNystatin
Nystatin
Nystaform, Nystatin, Nystop (nystatin) is a small molecule pharmaceutical. Nystatin was first approved as Nystaform on 1982-01-01. It is used to treat chronic mucocutaneous candidiasis, cutaneous candidiasis, mycoses, oral candidiasis, and vulvovaginal candidiasis in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
stomatognathic diseasesD009057
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Nystatin, Nystop (discontinued: Candex, Mycostatin, Mykinac, Nilstat, Nysert, Nystatin, Nystex)
Combinations
Nystatin triamcinolone (discontinued: Myco-triacet, Mycolog-ii, Mykacet, Mytrex f, Nystaform, Nystatin triamcinolone, Nystatin-triamcinolone)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Nystatin
Tradename
Company
Number
Date
Products
CANDEXBayerN-050233 DISCN1982-01-01
1 products
NILSTATChartwell PharmaceuticalsN-050299 DISCN1982-01-01
1 products, RLD
MYCOSTATINDelcor AssetN-050619 DISCN1987-04-09
1 products
NILSTATStrides Pharma GlobalN-050576 DISCN1983-12-22
1 products, RLD
NYSERTWarner ChilcottN-050478 DISCN1982-01-01
1 products
Hide discontinued
Clioquinol
+
Nystatin
Tradename
Company
Number
Date
Products
NYSTAFORMBayerN-050235 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
klayestaANDA2024-12-19
mycostatinANDA2025-01-22
nyamycANDA2024-06-18
nystatinNDA authorized generic2025-03-25
nystatin and triamcinoloneANDA2011-05-10
nystatin and triamcinolone acetonideANDA2025-03-13
nystatin creamANDA2023-10-24
nystatin topical powderANDA2023-08-10
nystopANDA2024-12-24
triple antibioticOTC monograph final2017-05-05
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
mycoses—D009181B35-B49
atopic dermatitisEFO_0000274D003876L20
ulcerative colitisEFO_0000729D003093K51
ankylosing spondylitisEFO_0003898D013167M45
nephrotic syndromeEFO_0004255D009404N04
multiple sclerosisEFO_0003885D009103G35
uveitisEFO_1001231D014605H20.9
inflammationMP_0001845D007249—
pulmonary tuberculosisEFO_1000049D014397A15
adrenal insufficiency—D000309—
Show 27 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents
— A07A: Intestinal antiinfectives
— A07AA: Antibiotics, intestinal
— A07AA02: Nystatin
D: Dermatologicals
— D01: Antifungals for dermatological use
— D01A: Antifungals for topical use
— D01AA: Antifungal antibiotics, topical
— D01AA01: Nystatin
G: Genito urinary system and sex hormones
— G01: Gynecological antiinfectives and antiseptics
— G01A: Antiinfectives and antiseptics, excl. combinations with corticosteroids
— G01AA: Antibiotics, gynecological
— G01AA01: Nystatin
— G01AA51: Nystatin, combinations
HCPCS
No data
Clinical
No data
Drug
General
Drug common nameNystatin
INNnystatin
Description
Nystatin, sold under the brand name Mycostatin among others, is an antifungal medication. It is used to treat Candida infections of the skin including diaper rash, thrush, esophageal candidiasis, and vaginal yeast infections. It may also be used to prevent candidiasis in those who are at high risk. Nystatin may be used by mouth, in the vagina, or applied to the skin.
...
More
Classification
Small molecule
Drug classenzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2
Identifiers
PDB—
CAS-ID1400-61-9
RxCUI7597
ChEMBL IDCHEMBL450895
ChEBI ID—
PubChem CID14960
DrugBankDB00646
UNII IDBDF1O1C72E (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Nystatin
+
Lidocaine
+
Diphenhydramine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Nystatin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Nystatin
+
Triamcinolone
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use